Eribulin showed clinical activity with a manageable safety profile in previously treated Japanese patients with advanced/metastatic soft tissue sarcoma.
No takes yet. Share an insight, caveat, or question.
Kawai et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: